Advertisement.

ELGXQ Projected Dividend Yield

Endologix Inc ( OTCBB : ELGXQ )

Endologix develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. Co.'s products are designed for the endovascular treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: endovascular aneurysm repair (EVAR); or endovascular aneurysm sealing (EVAS), Co.'s solution for sealing the aneurysm sac while maintaining blood flow. Co.'s EVAR products include the AFX® Endovascular AAA System, the VELA® Proximal Endograft, and the Ovation® Abdominal Stent Graft System. Co.'s EVAS product is the Nellix® Endovascular Aneurysm Sealing System.

20 YEAR PERFORMANCE RESULTS

ELGXQ Dividend History Detail
ELGXQ Dividend News
ELGXQ Competitors News

# of Shares: 0

Closing Price: 0.02

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000